Loading...

APC anti-mouse IFN-γ Antibody

Pricing & Availability
Clone
XMG1.2 (See other available formats)
Regulatory Status
RUO
Other Names
Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
XMG1dot2_APC_032808
PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with XMG1.2 APC and B220 (RA3-6B2) PE
  • XMG1dot2_APC_032808
    PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with XMG1.2 APC and B220 (RA3-6B2) PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
505809 25 µg 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
505810 100 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IFN-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
E. coli-expressed, recombinant mouse IFN-γ
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The IFN-γ antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-γ-producing cells within mixed cell populations.
Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-γ. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IFN-γ bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-γ in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended.

Application References
  1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
  2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
  3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
  4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
  6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
  7. Ferrick D, et al. 1995. Nature 373:255. (FC)
  8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
  10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
  11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
  14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
  16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
  17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
  18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
  19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
  21. Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
  22. Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
  23. Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)
Product Citations
  1. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  2. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  3. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  4. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  5. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  6. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  7. Chinta KC et al. 2018. Cell reports. 25(7):1938-1952 . PubMed
  8. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  9. Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed
  10. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  11. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  12. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  13. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  14. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  15. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  16. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  17. Stone ET, et al. 2022. Cell Rep. 38:110388. PubMed
  18. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  19. Qu L, et al. 2022. Cell. 185:1728. PubMed
  20. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  21. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  22. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  23. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  24. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  25. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  26. Balood M, et al. 2022. Nature. 611:405. PubMed
  27. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  28. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  29. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  30. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  31. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  32. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  33. Xiao J, et al. 2023. J Clin Invest. 133: . PubMed
  34. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  35. Cheng H, et al. 2023. Nat Metab. 5:314. PubMed
  36. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  37. Vijver SV, et al. 2023. Front Immunol. 13:1100730. PubMed
  38. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  39. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  40. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  41. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  42. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  43. Du J, et al. 2022. Sci Immunol. 7:eabo5407. PubMed
  44. Wang Z, et al. 2022. J Control Release. 349:929. PubMed
  45. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  46. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  47. Shi X, et al. 2023. iScience. 26:106143. PubMed
  48. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  49. Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed
  50. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  51. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  52. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  53. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  54. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  55. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  56. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  57. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  58. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  59. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  60. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  61. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  62. Du C, et al. 2016. Nat Commun. 7: 11120. PubMed
  63. Cella M, et al. 2019. Nat Immunol. 1.513888889. PubMed
  64. Xie A et al. 2017. Endocrinology. 158(10):3140-3151 . PubMed
  65. Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed
  66. Yang N, et al. 2022. NPJ Vaccines. 7:120. PubMed
  67. Muthumani K, et al. 2015. Sci Transl Med. 7: 301ra132. PubMed
  68. Laroche-Lefebvre C, et al. 2016. J Immunol. 197: 3618 - 3627. PubMed
  69. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  70. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  71. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  72. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Yang C, et al. 2018. J Immunol. 200:1316. PubMed
  75. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  76. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  77. Gu M, et al. 2021. Nat Immunol. 22:193. PubMed
  78. Yang X, et al. 2021. Front Pharmacol. 12:771046. PubMed
  79. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  80. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  81. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  82. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  83. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  84. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  85. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  86. Zhao Y, et al. 2015. PLoS One. 10: 0134797. PubMed
  87. Burrack AL, et al. 2019. Cell Rep. 28:2140. PubMed
  88. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  89. Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed
  90. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  91. Lu J, et al. 2018. ACS Nano. 12:11041. PubMed
  92. Diao L, et al. 2022. iScience. 25:105511. PubMed
  93. Guo Q, et al. 2021. Front Cardiovasc Med. 8:633212. PubMed
  94. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  95. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  96. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  97. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  98. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  99. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  100. Matsuoka S, et al. 2019. Haematologica. 105:226. PubMed
  101. Saini V, et al. 2020. Nat Commun. 0.845138889. PubMed
  102. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  103. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  104. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  105. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  106. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  107. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  108. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  109. Cabrera-Mora M, et al. 2015. Infect Immun . 83: 3749-3761. PubMed
  110. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  111. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  112. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  113. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  114. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  115. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  116. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  117. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  118. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  119. Mills C, et al. 2022. Cells. 11:. PubMed
  120. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  121. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  122. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  123. Lai C, et al. 2009. Invest Ophthalmol Vis Sci. 50:4279. PubMed
  124. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  125. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  126. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  127. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  128. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  129. Zhu XG, et al. 2020. Cell Metabolism. 33(1):211-221.e6. PubMed
  130. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  131. Domeier P, et al. 2016. J Exp Med. 213: 715 - 732. PubMed
  132. Harty J 2009. Infect Immun. 77:1894. PubMed
  133. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  134. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  135. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  136. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  137. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  138. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  139. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  140. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  141. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  142. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  143. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  144. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  145. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  146. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  147. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  148. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  149. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  150. Bhattacharya D, et al. 2014. J Biol Chem. 289:16508. PubMed
  151. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  152. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  153. Yuan Y, et al. 2022. Cell Rep. 38:110256. PubMed
  154. Takeshita Y, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  155. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  156. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  157. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  158. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  159. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  160. Baban B, et al. 2021. JCI Insight. 6:00. PubMed
  161. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  162. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  163. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  164. Park JY, et al. 2019. Cell Rep. 27:2548. PubMed
  165. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  166. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  167. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  168. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  169. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  170. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  171. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  172. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  173. Huang F, et al. 2018. Oncoimmunology. 7:e1450713. PubMed
  174. Levesque S, et al. 2019. Oncoimmunology. 8:e1657375. PubMed
  175. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  176. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  177. Li YN, et al. 2022. Nat Commun. 13:4074. PubMed
  178. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  179. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  180. Dai R, et al. 2021. Front Immunol. 12:727046. PubMed
  181. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  182. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  183. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  184. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  185. Tonkin D, et al. 2008. J Immunol. 181:4516. PubMed
  186. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  187. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  188. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  189. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  190. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  191. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  192. Dudeck J, et al. 2019. J Allergy Clin Immunol. 143:1849. PubMed
  193. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  194. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  195. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  196. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  197. Zhang X, et al. 2021. Front Pharmacol. 12:629513. PubMed
  198. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  199. Dekhtiarenko I, et al. 2016. PLoS Pathog. 12:e1006072. PubMed
  200. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  201. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  202. Jin R, et al. 2008. J Immunol. 180:2256. PubMed
  203. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  204. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  205. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  206. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  207. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  208. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  209. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  210. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  211. Gupta S, et al. 2022. Life Sci. 288:120182. PubMed
  212. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  213. Moon J, et al. 2020. Immune Netw. 20:e40. PubMed
  214. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  215. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  216. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  217. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  218. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  219. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  220. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  221. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  222. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  223. Hartwig S, et al. 2014. PLoS One. 9:90720. PubMed
  224. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  225. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  226. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  227. Kurihara T, et al. 2015. PLoS One. 10: e0139692. PubMed
  228. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  229. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  230. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  231. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  232. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  233. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  234. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  235. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  236. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  237. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  238. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  239. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  240. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  241. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  242. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  243. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  244. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  245. Yang N, et al. 2021. NPJ Precis Oncol. 5:37. PubMed
  246. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  247. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  248. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  249. Sheng J, et al. 2021. eLife. 10:00. PubMed
  250. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  251. Bransi A, et al. 2015. Cancer Immunol Res. 3: 1279 - 1288. PubMed
  252. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  253. Kwak JE, et al. 2019. Nat Commun. 10:3836. PubMed
  254. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  255. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  256. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  257. Li M, et al. 2020. J Immunother Cancer. 8:00. PubMed
  258. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  259. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  260. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  261. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  262. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  263. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  264. Kalim KW, et al. 2021. Front Immunol. 12:726393. PubMed
  265. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  266. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  267. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  268. Jackson C, et al. 2016. Clin Cancer Res. 22: 1161 - 1172. PubMed
  269. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  270. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_315403 (BioLegend Cat. No. 505809)
AB_315403 (BioLegend Cat. No. 505810)

Antigen Details

Structure
Cytokine; dimer; 40-80 kD (Mammalian)
Bioactivity
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Targets
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.

Regulation
Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account